| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Harrison PV | Retinoids and the gastric mucosa. | 1983 | Br. J. Dermatol. | pmid:6860570 |
| Claudy AL et al. | Treatment of cutaneous lymphoma with etretinate. | 1983 | Br. J. Dermatol. | pmid:6860571 |
| Kitajima Y and Mori S | Effects of retinoid (Ro 10-9359) on the plasma membrane of keratinocytes in patients with psoriasis: a freeze-fracture analysis. | 1983 | J. Invest. Dermatol. | pmid:6186751 |
| Hönigsmann H and Wolff K | Isotretinoin-PUVA for psoriasis. | 1983 | Lancet | pmid:6130263 |
| Kanerva L et al. | Ultrastructure of pityriasis rubra pilaris with observations during retinoid (etretinate) treatment. | 1983 | Br. J. Dermatol. | pmid:6190496 |
| Bialasiewicz AA et al. | Immunomodulating properties and tissue distribution of aromatic retinoids in the immunologically responsive albino rabbit eye. | 1983 | Graefes Arch. Clin. Exp. Ophthalmol. | pmid:6629019 |
| Ruiz-Maldonado R and Tamayo L | Retinoids in keratinizing diseases and acne. | 1983 | Pediatr. Clin. North Am. | pmid:6193480 |
| Pigatto PD et al. | Effect of etretinate on chemotaxis of neutrophils from patients with pustular and vulgar psoriasis. | 1983 | J. Invest. Dermatol. | pmid:6631053 |
| Sönnichsen N et al. | [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)]. | 1983 | Z. Hautkr. | pmid:6636927 |
| Williamson DM and Greenwood R | Multiple pyogenic granulomata occurring during etretinate therapy. | 1983 | Br. J. Dermatol. | pmid:6639883 |
| Haftek M et al. | Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. | 1983 | J. Invest. Dermatol. | pmid:6345681 |
| Fritsch P et al. | Retinoid therapy of recessive dystrophic epidermolysis bullosa. | 1983 | J. Am. Acad. Dermatol. | pmid:6643774 |
| Kansky A and Paljan D | [Etretinate in the treatment of psoriasis and other skin diseases]. | 1983 | Lijec Vjesn | pmid:6656529 |
| Baran R et al. | [Transverse leukonychia induced by etretinate]. | 1983 | Ann Dermatol Venereol | pmid:6660763 |
| Souteyrand P et al. | [Sneddon-Wilkinson's subcorneal pustulosis and monoclonal IgA dysglobulinemia: favorable effect of Tigason]. | 1983 | Ann Dermatol Venereol | pmid:6660787 |
| Abdel-Aal MA | Treatment of systematized verrucous epidermal naevus by aromatic retinoid (Ro. 10-9359). | 1983 | Clin. Exp. Dermatol. | pmid:6661828 |
| Gollnick H and Orfanos CE | [Clinico-therapeutic index and dosimetry of oral treatment with aromatic retinoid. A comparison of different dosages]. | 1983 | Hautarzt | pmid:6662724 |
| Kanerva L et al. | New observations on the fine structure of lamellar ichthyosis and the effect of treatment with etretinate. | 1983 | Am J Dermatopathol | pmid:6666837 |
| Sterry W et al. | [Etretinate in a case of benign familial pemphigus]. | 1983 | Ann Dermatol Venereol | pmid:6666932 |
| Hall RP et al. | Circulating IgA immune complexes in patients with psoriasis. | 1983 | J. Invest. Dermatol. | pmid:6602187 |
| Lubach D | [Psoriasis vulgaris. 2. Problems of the psoriatic patient--therapeutic possibilities]. | 1983 | Krankenpfl J | pmid:6556385 |
| Bauer EA et al. | Retinoic acid inhibition of collagenase and gelatinase expression in human skin fibroblast cultures. Evidence for a dual mechanism. | 1983 | J. Invest. Dermatol. | pmid:6308104 |
| Marcelo CL and Tomich J | Cyclic AMP, glucocorticoid, and retinoid modulation of in vitro keratinocyte growth. | 1983 | J. Invest. Dermatol. | pmid:6306118 |
| Dowd PM and Munro DD | Ichthyosis and osteopetrosis. | 1983 | J R Soc Med | pmid:6864708 |
| DiGiovanna JJ and Peck GL | Oral synthetic retinoid treatment in children. | 1983 | Pediatr Dermatol | pmid:6238291 |
| Fraki JE et al. | Correlation of epidermal plasminogen activator activity with disease activity in psoriasis. | 1983 | Br. J. Dermatol. | pmid:6336944 |
| Fernandes Rodrigues JC et al. | [Follicular psoriasis with cicatricial alopecia. Piccardi-Lassueur-Graham Little syndrome of a psoriatic nature]. | 1983 | Med Cutan Ibero Lat Am | pmid:6348436 |
| Tagami H et al. | Subcorneal pustular dermatosis with vesiculo-bullous eruption. Demonstration of subcorneal IgA deposits and a leukocyte chemotactic factor. | 1983 | Br. J. Dermatol. | pmid:6357264 |
| Wolska H et al. | Etretinate in severe psoriasis. Results of double-blind study and maintenance therapy in pustular psoriasis. | 1983 | J. Am. Acad. Dermatol. | pmid:6358282 |
| Torne Escasany R et al. | [Generalized Mibelli's porokeratosis in transformation to spinocellular carcinoma. Clinical, histologic and ultrastructural study. Favorable response to RO-109359]. | 1983 | Med Cutan Ibero Lat Am | pmid:6366389 |
| Mashkilleysson AL and Mashkilleysson NA | [Treatment of congenital erythroderma ichthyosiforme in mother and son with the oral aromatic retinoid Ro 10-9359. The need for maintenance therapy]. | 1983 | Z. Hautkr. | pmid:6415945 |
| Luderschmidt C and Balda BR | [Reiter's disease. Effective combination drug therapy with methotrexate, etretinate and prednisolone]. | 1983 | MMW Munch Med Wochenschr | pmid:6417500 |
| Fujita J et al. | Therapeutic effect of a retinoid (Ro 10-9359) on rats with bladder tumours induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine upon administration alone or in combination with mitomycin C. | 1983 | Urol. Res. | pmid:6419428 |
| Vignale RA et al. | [Epidermic chalone receptors in psoriasis treated with retinoid:Ro 10-9359]. | 1983 | Med Cutan Ibero Lat Am | pmid:6314070 |
| Bonnetblanc JM et al. | Intracranial hypertension with etretinate. | 1983 | Lancet | pmid:6138537 |
| Kaplan RP et al. | Etretinate therapy for psoriasis: clinical responses, remission times, epidermal DNA and polyamine responses. | 1983 | J. Am. Acad. Dermatol. | pmid:6826812 |
| Pang AS and Morales A | Chemoimmunoprophylaxis of an experimental bladder cancer with retinoids and Bacillus Calmette Guérin. | 1983 | J. Urol. | pmid:6575192 |
| Weber W et al. | [Etretinate (Ro 10-9359, Tigason) and CCNU (1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea) and bleomycin versus CCNU and bleomycin in the treatment of advanced squamous cell carcinoma of the bronchus (Working group on Internal Medicine Oncology Study BS1/78)]. | 1983 | Onkologie | pmid:6191263 |
| Kariniemi AL et al. | Surface glycoproteins of cultured human keratinocytes from normal and uninvolved psoriatic epidermis. | 1983 | Br. J. Dermatol. | pmid:6196046 |
| Sharma SC and Simpson NB | Treatment of arsenical keratosis with etretinate. | 1983 | Acta Derm. Venereol. | pmid:6197851 |
| El-Ramly M and Zachariae H | Long-term oral treatment of two pronounced ichthyotic conditions: lamellar ichthyosis and epidermolytic hyperkeratosis with the aromatic retinoid, Tigason (RO 10-9359). | 1983 | Acta Derm. Venereol. | pmid:6197852 |
| Fontan B et al. | Toxic effects of the aromatic retinoid etretinate. | 1983 | Arch Dermatol | pmid:6824354 |
| Kitajima Y et al. | Effects of oral retinoid on the SDS-PAGE profile of stratum corneum keratin in patients with psoriasis. | 1983 | J. Dermatol. | pmid:6199394 |
| Grekin RC et al. | Decreased urinary polyamines in patients with psoriasis treated with etretinate. | 1983 | J. Invest. Dermatol. | pmid:6827127 |
| Orfanos CE and Bauer R | Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience. | 1983 | Br. J. Dermatol. | pmid:6222758 |
| Baran R and Juhlin L | Keratodermia palmoplantare papuloverrucoides progressiva: successful treatment with etretinate. | 1983 | J. Am. Acad. Dermatol. | pmid:6223052 |
| Ward A et al. | Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders. | 1983 | Drugs | pmid:6224672 |
| Farber EM et al. | Recent advances in the treatment of psoriasis. | 1983 | J. Am. Acad. Dermatol. | pmid:6833533 |
| Boyle J et al. | Treatment of extensive virus warts with etretinate (Tigason) in a patient with sarcoidosis. | 1983 | Clin. Exp. Dermatol. | pmid:6839535 |
| Etretinate (Tigason) for skin disease. | 1983 | Drug Ther Bull | pmid:6839967 |
Etretinate
Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.
Cross Reference
Introduction
To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Etretinate?
Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Etretinate
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Etretinate?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Etretinate?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Etretinate?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Etretinate?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Etretinate?
There are no associated biomedical information in the current reference collection.